BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9032379)

  • 1. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
    Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
    J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.
    Koyanagi Y; Tanaka Y; Tanaka R; Misawa N; Kawano Y; Tanaka T; Miyasaka M; Ito M; Ueyama Y; Yamamoto N
    Leukemia; 1997 Apr; 11 Suppl 3():109-12. PubMed ID: 9209314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
    J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
    Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
    Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
    Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
    Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
    Miura Y; Misawa N; Maeda N; Inagaki Y; Tanaka Y; Ito M; Kayagaki N; Yamamoto N; Yagita H; Mizusawa H; Koyanagi Y
    J Exp Med; 2001 Mar; 193(5):651-60. PubMed ID: 11238596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.
    Gorantla S; Santos K; Meyer V; Dewhurst S; Bowers WJ; Federoff HJ; Gendelman HE; Poluektova L
    J Virol; 2005 Feb; 79(4):2124-32. PubMed ID: 15681415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.
    Zhang L; Meissner E; Chen J; Su L
    Sci China Life Sci; 2010 Feb; 53(2):195-203. PubMed ID: 20596827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
    Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
    Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High activation and skewed T cell differentiation are associated with low IL-17A levels in a hu-PBL-NSG-SGM3 mouse model of HIV infection.
    Perdomo-Celis F; Medina-Moreno S; Davis H; Bryant J; Taborda NA; Rugeles MT; Kottilil S; Zapata JC
    Clin Exp Immunol; 2020 May; 200(2):185-198. PubMed ID: 31951011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.
    Wu SJ; Hayes CG; Dubois DR; Windheuser MG; Kang YH; Watts DM; Sieckmann DG
    Am J Trop Med Hyg; 1995 May; 52(5):468-76. PubMed ID: 7771614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.
    Beaman MH; Remington JS; Meyer DJ
    Immunol Cell Biol; 2000 Dec; 78(6):608-15. PubMed ID: 11114971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
    Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
    J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus infection of human-PBL-SCID mice.
    Mosier DE; Gulizia RJ; Baird SM; Wilson DB; Spector DH; Spector SA
    Science; 1991 Feb; 251(4995):791-4. PubMed ID: 1990441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.